首页> 外文会议>Portland International Conference on Management of Engineering and Technology >Structural Characteristics of Venture Companies Network in Japanese Biotech Industry
【24h】

Structural Characteristics of Venture Companies Network in Japanese Biotech Industry

机译:日本生物技术产业风险企业网络的结构特征

获取原文

摘要

Bio-tech venture companies' which have broad alliance network tend to grow and to be listed (=IPO). In addition, it is necessary for venture companies to accumulate internal resources and capability. That is, both structural characteristics of the network and internal resources are important for the venture growth in the pharmaceutical industries. As an analysis target, we covered 186 pharmaceutical manufacturing and reagent manufacturing venture companies established in Japan, from 1995 to 2015. Then we classified our collection of data mainly into three groups; IPO ventures, subsidiaries and others. With our data, analysis of variance was conducted. As a result of analyzing partnerships, IPO ventures have different positions from other companies in ‘betweenness’. That is, IPO ventures partly have the function as the bridge of the research and development group in the network.
机译:具有广泛联盟网络的生物技术风险投资公司趋向于成长并上市(= IPO)。另外,风险投资公司必须积累内部资源和能力。也就是说,网络的结构特征和内部资源对于制药行业的风险成长都很重要。作为分析目标,我们覆盖了1995年至2015年在日本成立的186家制药和试剂制造风险公司。然后,我们将数据收集主要分为三类:首次公开发行企业,子公司和其他。利用我们的数据,进行了方差分析。通过分析合作伙伴关系,IPO企业在“中间性”方面与其他公司的立场不同。也就是说,IPO合资企业部分地起到了网络中研发团队的桥梁的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号